Company intelligence / Profile preview

Maytal Capital

Unknown, Unknown, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Maytal Capital is a private equity and venture capital investment and advisory firm focused on the healthcare sector. Founded in 2017 by Jeff George, it invests in and advises companies across the life sciences, biotech, pharma, diagnostics, medical devices, and related healthcare industries. The firm does not appear to have its own clinical pipeline but is involved with portfolio companies at various stages of development[1][2][3][10].

Industry: Investors

Drug pipeline

7 assets

CREXONT

Commercial

Indications: Parkinson's disease

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Maytal Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maytal Capital.

Explore the full profile